Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

#RemoteDetailing

- PMLiVE

EMA fast-tracks review of bluebird bio’s LentiGlobin for sickle cell disease

Gene therapy has been given a PRIME designation

Andrew Smith

Crisis? No problem!

Issues planning & management for pharma spokespeople, by Andrew Smith

Havas Life London

- PMLiVE

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

UK human ‘challenge trial’ programme would be a world first

- PMLiVE

Keytruda doubles five-year survival rate in NSCLC

Merck reveals long-term efficacy data for blockbuster immunotherapy

- PMLiVE

Could formulary intelligence be your brand differentiator?

Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch

- PMLiVE

Relief Therapeutics seeks US emergency approval for COVID-19 drug

If granted, EUA would give approval for use in severely ill patients with no other treatment options

- PMLiVE

How COVID-19 is accelerating the threat of antimicrobial resistance

Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19

- PMLiVE

FDA hands BMS and bluebird bio a priority review for ide-cel

Updated review accepted after refuse-to-file letter was issued in May

- PMLiVE

Porterhouse Medical strengthens its senior management team

Announcing the well-deserved promotion of Erica Cave

Porterhouse Medical Group

- PMLiVE

Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Positive interim results presented at 2020 ESMO virtual congress

- PMLiVE

OPEN Health’s Digital team have won a Bronze Award at the PM Society Digital Awards 2020

We are delighted to have won another Bronze Award at the PM Society Digital Awards 2020in the Healthcare Charities & Patient Associations Category for Alexander Devine Children's Hospice Service. READ MORE ABOUT OUR...

OPEN Health

- PMLiVE

AZ/Merck’s Lynparza improves survival in certain prostate cancers

New data released at ESMO 2020 virtual congress shows drug cuts the risk of death

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links